Literature DB >> 19729428

Association of dialysis modality and cardiovascular mortality in incident dialysis patients.

David W Johnson1, Hannah Dent, Carmel M Hawley, Stephen P McDonald, Johan B Rosman, Fiona G Brown, Kym Bannister, Kathryn J Wiggins.   

Abstract

BACKGROUND AND OBJECTIVES: The aim of the investigation presented here was to compare the rates, causes, and timing of cardiovascular (CV) death in incident peritoneal dialysis (PD) and hemodialysis (HD) patients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The study included all adult Australian and New Zealand patients commencing dialysis between January 1, 1997 and December 31, 2007. Rates of and times to CV death were compared by incident rate ratios, cumulative incidence, and multivariable Cox proportional hazards model analyses. Dialysis modality was included in the model as a time-varying covariate, and a competing risks approach was used to obtain cause-specific hazard ratios.
RESULTS: Of the 24,587 patients who commenced dialysis (first treatment PD n = 6521; HD n = 18,066) during the study, 5669 (21%) died from CV causes [PD 2044 (28%) versus HD 3625 (21%)]. The incidence rates of CV mortality in PD and HD patients were 9.99 and 7.96 per 100 patient-years, respectively (incidence rate ratio PD versus HD, 1.25; 95% confidence interval 1.12 to 1.32). PD was consistently associated with an increased hazard of CV death compared with HD after 1 yr of treatment. This increased risk in PD patients was largely accounted for by an increased risk of death due to myocardial infarction.
CONCLUSIONS: Dialysis modality is significantly associated with the risk, causes, and timing of CV death experienced by ESRD patients in Australia and New Zealand.

Entities:  

Mesh:

Year:  2009        PMID: 19729428      PMCID: PMC2758255          DOI: 10.2215/CJN.01750309

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  45 in total

1.  Outcomes of acute coronary syndrome in a large Canadian cohort: impact of chronic renal insufficiency, cardiac interventions, and anemia.

Authors:  Tammy M Keough-Ryan; Bryce A Kiberd; Christine S Dipchand; Jafna L Cox; Caren L Rose; Kara J Thompson; Catherine M Clase
Journal:  Am J Kidney Dis       Date:  2005-11       Impact factor: 8.860

Review 2.  Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective.

Authors:  C Zoccali
Journal:  Kidney Int       Date:  2006-05-24       Impact factor: 10.612

3.  Controlled comparison of hemodialysis and peritoneal dialysis: Veterans Administration multicenter study.

Authors:  R A Gutman; M J Blumenkrantz; Y K Chan; G L Barbour; V C Gandhi; F H Shen; T Tucker; B J Murawski; J W Coburn; F K Curtis
Journal:  Kidney Int       Date:  1984-10       Impact factor: 10.612

4.  The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis.

Authors:  Edward F Vonesh; Jon J Snyder; Robert N Foley; Allan J Collins
Journal:  Kidney Int       Date:  2004-12       Impact factor: 10.612

5.  Survival and development of cardiovascular disease by modality of treatment in patients with end-stage renal disease.

Authors:  Francesco Locatelli; Daniele Marcelli; Ferruccio Conte; Marco D'Amico; Lucia Del Vecchio; Aurelio Limido; Fabio Malberti; Donatella Spotti
Journal:  J Am Soc Nephrol       Date:  2001-11       Impact factor: 10.121

Review 6.  Mortality studies comparing peritoneal dialysis and hemodialysis: what do they tell us?

Authors:  E F Vonesh; J J Snyder; R N Foley; A J Collins
Journal:  Kidney Int Suppl       Date:  2006-11       Impact factor: 10.545

7.  Comparative mortality of hemodialysis and peritoneal dialysis in Canada.

Authors:  S W Murphy; R N Foley; B J Barrett; G M Kent; J Morgan; P Barré; P Campbell; A Fine; M B Goldstein; S P Handa; K K Jindal; A Levin; H Mandin; N Muirhead; R M Richardson; P S Parfrey
Journal:  Kidney Int       Date:  2000-04       Impact factor: 10.612

8.  Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States.

Authors:  Austin G Stack; Donald A Molony; Noor S Rahman; Akinsansoye Dosekun; Bhamidipati Murthy
Journal:  Kidney Int       Date:  2003-09       Impact factor: 10.612

9.  Hemodialysis and peritoneal dialysis: comparison of adjusted mortality rates according to the duration of dialysis: analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis 2.

Authors:  Fabian Termorshuizen; Johanna C Korevaar; Friedo W Dekker; Jeannette G Van Manen; Elisabeth W Boeschoten; Raymond T Krediet
Journal:  J Am Soc Nephrol       Date:  2003-11       Impact factor: 10.121

10.  Continuous ambulatory peritoneal dialysis and hemodialysis: comparison of patient mortality with adjustment for comorbid conditions.

Authors:  P J Held; F K Port; M N Turenne; D S Gaylin; R J Hamburger; R A Wolfe
Journal:  Kidney Int       Date:  1994-04       Impact factor: 10.612

View more
  34 in total

1.  Differences in coagulation between hemodialysis and peritoneal dialysis.

Authors:  Donald F Brophy; Daniel E Carl; Bassem M Mohammed; Jingmei Song; Erika J Martin; Jessica L Bostic; Todd W B Gehr
Journal:  Perit Dial Int       Date:  2013-12-01       Impact factor: 1.756

Review 2.  The Current State of Peritoneal Dialysis.

Authors:  Rajnish Mehrotra; Olivier Devuyst; Simon J Davies; David W Johnson
Journal:  J Am Soc Nephrol       Date:  2016-06-23       Impact factor: 10.121

3.  Neuronal damage and shortening of lifespan in C. elegans by peritoneal dialysis fluid: Protection by glyoxalase-1.

Authors:  Andrea Schlotterer; Friederike Pfisterer; Georgi Kukudov; Britta Heckmann; Daniel Henriquez; Christian Morath; Bernhard K Krämer; Hans-Peter Hammes; Vedat Schwenger; Michael Morcos
Journal:  Biomed Rep       Date:  2018-04-03

4.  Longitudinal Trend in Lipid Profile of Incident Peritoneal Dialysis Patients is Not Influenced by the Use of Biocompatible Solutions.

Authors:  Yeoungjee Cho; Janine Büchel; Sonja Steppan; Jutta Passlick-Deetjen; Carmel M Hawley; Goce Dimeski; Margaret Clarke; David W Johnson
Journal:  Perit Dial Int       Date:  2015-10-01       Impact factor: 1.756

5.  Baseline serum interleukin-6 predicts cardiovascular events in incident peritoneal dialysis patients.

Authors:  Yeoungjee Cho; David W Johnson; David A Vesey; Carmel M Hawley; Elaine M Pascoe; Margaret Clarke; Nicholas Topley
Journal:  Perit Dial Int       Date:  2014-04-07       Impact factor: 1.756

6.  Insulin resistance as a predictor of cardiovascular disease in patients on peritoneal dialysis.

Authors:  Yun Li; Lihua Zhang; Yong Gu; Chuanming Hao; Tongying Zhu
Journal:  Perit Dial Int       Date:  2013-03-01       Impact factor: 1.756

Review 7.  Assessment of cardiac structure and function in kidney failure: understanding echocardiography and magnetic resonance imaging for the nephrologist.

Authors:  Dharmenaan Palamuthusingam; Reza Reyaldeen; David Wayne Johnson; Camel M Hawley; Elaine M Pascoe; Sudhir Wahi; Magid Fahim
Journal:  Int Urol Nephrol       Date:  2020-08-31       Impact factor: 2.370

8.  Impact of dialysis modality on the survival of patients with end-stage renal disease and prior stroke.

Authors:  I-Kuan Wang; Wen-Miin Liang; Cheng-Li Lin; Yao-Lung Liu; Chiz-Tzung Chang; Tzung-Hai Yen; Chiu-Ching Huang; Fung-Chang Sung
Journal:  Int Urol Nephrol       Date:  2015-11-11       Impact factor: 2.370

Review 9.  Comparison of cardiovascular mortality in hemodialysis versus peritoneal dialysis.

Authors:  Cheng Han Ng; Zhi Hao Ong; Hersharan Kaur Sran; Teo Boon Wee
Journal:  Int Urol Nephrol       Date:  2020-10-28       Impact factor: 2.370

10.  Insulin Resistance in Nondiabetic Peritoneal Dialysis Patients: Associations with Body Composition, Peritoneal Transport, and Peritoneal Glucose Absorption.

Authors:  Ana Paula Bernardo; Jose C Oliveira; Olivia Santos; Maria J Carvalho; Antonio Cabrita; Anabela Rodrigues
Journal:  Clin J Am Soc Nephrol       Date:  2015-10-27       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.